Pregnancy, Ovulation, and Fertility Testing Kits Market Size, Share, and Analysis, By Product Type (Pregnancy Testing Kits, Ovulation Testing Kits, and Fertility Testing Kits), By Device Type (Line Indicator Devices and Digital Devices), By Technology (Lateral Flow Immunoassay, Enzyme-linked Immunosorbent Assay, Chemiluminescent Immunoassay, and Others), By Sample Type (Urine, Blood, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

Pregnancy, ovulation, and fertility testing kits are tools that women utilize to track their menstrual cycle, detect ovulation, and determine pregnancy at home. These kits involve the utilization of samples such as blood, urine, saliva, and semen. The ovulation test detects an increase in the luteinizing hormone (LH) in the urine. In contrast, pregnancy tests are done by detecting the special hormone, human chorionic gonadotropin (HCG), which only develops in a woman’s body during pregnancy.

Fertility testing in females includes the detection of hormone levels and ovarian reserve. In contrast, in males, fertility testing involves semen analysis screening and sperm count tests. The falling fertility rate and rising concerns regarding both male and female infertility has increased the demand for fertility testing, driving the growth of fertility testing kits.

• For instance, in March 2023, according to the BBC, a review of global trends in sperm count was published by researchers in 2022, which highlighted that sperm counts fell on average by 1.2% annually between 1973 and 2018, from 104 to 49 million/ml. The rate of decline increased by over 2.6% per year after 2000.


• As per the United Nations Population Fund, the fertility rate has dropped from an average of 5.0 births per woman in 1950 to 2.3 births per woman in 2021 globally. Moreover, the overall fertility rate is expected to decline to 2.1 births per woman by 2050.


• According to the World Health Organization (WHO), in April 2023, approximately one in six individuals was affected by infertility worldwide.

The rising awareness of fertility health and taking steps to optimize conception and avoid unwanted pregnancies has fueled the demand for the adoption of pregnancy and ovulation testing kits across the globe. Moreover, technological advancements have made these kits more accurate and user-friendly to detect the respective conditions, driving the market growth.

• For instance, according to BMC Health, in June 2023, a study conducted by researchers about fertility awareness (FA) stated that college students in their reproductive age have a common understanding of fertility, assisted reproductive technologies, and risk factors for infertility.

Moreover, early detection of pregnancy aids women to make important decisions regarding their health and the health of their baby. Rapid-detection pregnancy kits allow women to detect pregnancy at an early stage. Therefore, the rising demand for early detection of pregnancy propels the market growth.

Impact of COVID-19 on the Pregnancy, Ovulation, and Fertility Testing Kits Market

The global pregnancy, ovulation, and fertility testing kits market witnessed a slightly negative impact during the COVID-19 pandemic. During the crisis, the supply chain was disrupted, which led to an insufficient supply of these kits.

• For instance, in December 2020, according to the NCBI, a survey among ovulation and pregnancy kit customers in the U.S. expressed reluctance to conceive babies. Moreover, the survey also highlighted a decreased supply of ovulation and pregnancy testing kits.

Several hospitals advised the couples to halt their fertility treatment until the mitigation of the COVID-19 outbreak. A number of couples postponed the attempts at pregnancy or delayed fertility care due to concerns about COVID-19 disease. However, the at-home fertility tests experienced a significant increase due to the closure of fertility clinics. Companies primarily focused on at-home pregnancy, ovulation, and fertility testing kits, which helped the market regain its momentum after the first year of the pandemic.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Infertility, By Key Countries/Regions, 2023


• Technological Advancements in Pregnancy, Ovulation and Fertility Testing Kits


• New Product Launches, By Key Players


• Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)


• Impact of COVID-19 on the Market

Analysis by Product Type

Based on product type, the pregnancy testing kits are expected to hold a significant market share during the forecast period. The segment growth is mainly influenced by the rising demand for early detection of pregnancy and at-home pregnancy testing kits. These kits further include line indicator devices (cassette, strip, and midstream tests) and digital display tests.

Among these, the line indicator devices are anticipated to hold a noteworthy market share as they offer several benefits such as cost-efficiency, self-care, and self-diagnosis of pregnancy. Moreover, companies are actively involved in new pregnancy testing product launches, which increase the availability of products, driving the market growth. 

• For instance, in June 2023, Salignostics, an Israeli biotech company, announced the launch of Salistick, the first saliva-based pregnancy test in the U.K.

Regional Analysis

To gain extensive insights into the market, Request for Customization

North America is anticipated to hold the largest share of the global pregnancy, ovulation, and fertility testing market. This growth is attributed to the rising demand for self-testing pregnancy kits among working women in this region. Moreover, the growing acceptance of premarital sex in this region also increases the demand for pregnancy testing in this region. In addition, the rising disposable incomes in the U.S. also contribute to the increased spending on healthcare products, including pregnancy, ovulation, and fertility testing kits. As a result, the sale of these kits has increased in the region in recent years, driving the market growth.

• For instance, in November 2021, according to the Poynter Institute for Media Studies, Inc., Nielsen and Bank of America reported that the sales of pregnancy tests in the U.S., including kits, have grown by an average of 13% year over year since June 2020.

The Asia Pacific market is projected to expand at a significant rate over the forecast period. The growth can be credited to the presence of a large and growing female population in countries such as India. Moreover, government initiatives to promote pre-natal services in China and India boost the demand for pregnancy testing kits, which propels the market growth in the Asia Pacific region.

Key Players Covered

The report includes the profiles of key players such as Abbott, Swiss Precision Diagnostics GmbH, Church & Dwight Co., Inc., Germaine Laboratories, Inc., Quidel Corporation (QuidelOrtho Corporation), Proov, AVA Sciences-FMTC LLC, Mankind Pharma, Quest Diagnostics Incorporated, FAIRHAVEN HEALTH, and others.

Key Industry Developments

• In August 2023, Fertilly GmbH announced the European launch of Fertility Kits with micro sampling devices. This at-home testing kit is powered by dried blood microsampling with VAMS technology.


• In July 2023, Quest Diagnostics Incorporated and Proov entered a collaboration to provide a Proov Confirm PdG Test Kit to women to detect ovulation at home through questhealth.com.


• In January 2022, Kindbody announced the launch of a 'Kind at Home' fertility hormone test kit for both men and women to determine their fertility status in the comfort of their homes.